CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-03-08 | TOBIN JAMES R Director | Option exercise · Non-qualified stock option | −2,500 | $1.09 | $3K | 0 |
| 2012-01-30 | MCNAB JAMES R Director | Option exercise | +85,000 | $2.15 | $183K | 0 |
| 2012-01-30 | MCNAB JAMES R Director | Option exercise | +87,500 | $2.43 | $213K | 0 |
| 2012-01-30 | MCNAB JAMES R Director | Option exercise | +85,000 | $2.27 | $193K | 1,379,688 |
| 2012-01-30 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +85,000 | $2.15 | $183K | 0 |
| 2012-01-30 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +87,500 | $2.43 | $213K | 0 |
| 2012-01-30 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +85,000 | $2.27 | $193K | 0 |
| 2012-01-05 | GRAY MICHAEL COO and CFO | Grant or award · Qualified stock option (right to buy) | +37,367 | 37,367 | ||
| 2012-01-05 | GRAY MICHAEL COO and CFO | Grant or award · Non-qualified stock option (right to buy) | +212,633 | 212,633 | ||
| 2012-01-05 | GRAY MICHAEL COO and CFO | Grant or award · Qualified stock option (right to buy) | +37,367 | 37,367 | ||
| 2012-01-05 | GRAY MICHAEL COO and CFO | Grant or award · Non-qualified stock option (right to buy) | +212,633 | 212,633 | ||
| 2012-01-05 | NOEL MARK VP, Tech Management | Grant or award · Qualified stock option (right to buy) | +44,450 | 44,450 | ||
| 2012-01-05 | NOEL MARK VP, Tech Management | Grant or award · Non-qualified stock option (right to buy) | +35,550 | 35,550 | ||
| 2012-01-05 | PASSERI DANIEL R CEO and Director | Grant or award · Qualified stock option (right to buy) | +38,301 | 38,301 | ||
| 2012-01-05 | PASSERI DANIEL R CEO and Director | Grant or award · Non-qualified stock option (right to buy) | +361,699 | 361,699 | ||
| 2012-01-05 | Voi Maurizio Chief Medical Officer | Grant or award · Non-qualified stock option (right to buy) | +93,750 | 93,750 | ||
| 2012-01-05 | Voi Maurizio Chief Medical Officer | Grant or award · Qualified stock option (right to buy) | +6,250 | 6,250 | ||
| 2012-01-05 | GREENACRE MARTYN D Director | Grant or award · Non-qualified stock option (right to buy) | +50,000 | 25,000 | ||
| 2012-01-05 | BAYH SUSAN B Director | Grant or award · Non-qualified stock option (right to buy) | +50,000 | 25,000 | ||
| 2012-01-05 | Rubin Marc Director | Grant or award · Non-qualified stock option (right to buy) | +50,000 | 25,000 |
Page 20 of 29 · 564 trades